In silico modeling promises to overcome the limitations of the in vitro and in vivo experimental models used to represent human biological systems, but also the limits on our cognitive capacities to store, analyze and represent the enormous amount of information needed to reliably and accurately capture system complexity and variability. The Avicenna project, a leading group for in silico clinical trials, will hold its 5th meeting in Barcelona on 4th – 5th June 2015. Taking this opportunity, our workshop – organized by Bio-Techno-Practice network in collaboration with IESE – will reflect on the philosophical foundations of in silico modeling and on the various implications of its biomedical applications: drugs, devices, and clinical trials.
This Interdisciplinary Workshop was held at University Campus Bio-Medico in Rome, February 5-6, 2015. Is it possible to obtain robustness artificially, or is it a natural property (i.e., is non-living systems robustness distinct from organismic robustness)? Which synthetic models may be inspired by the concept of robustness? In biological systems, robustness comes across different scales, from molecular to plant size and involves change and development aspects, thus becoming a pillar in their dynamics (see the previous Interdisciplinary Workshop on Robustness). What is the definition of robustness in engineering? Which application for the concept of robustness? What technologies does robustness inspire? Continue reading Robustness – Engineering Science